Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study

1. Raje, N.
2. Terpos, E.
3. Willenbacher, W.
4. Shimizu, K.
5. García-Sanz, R.
6. Durie, B.
7. Legieć, W.
8. Krejčí, M.
9. Laribi, K.
10. Zhu, L.
11. Cheng, P.
12. Warner, D.
13. Roodman, G.D.